News | June 11, 2009

Digirad to Show New SPECT/VCT at SNM 2009

June 12, 2009 - Digirad Corp., a provider of medical diagnostic imaging products and personnel and equipment leasing services, will feature at SNM its recently 510(k) cleared Cardius X-ACT imaging system.

Cardius X-ACT is a rapid cardiac SPECT/VCT imaging system that features a low-dose volume-computed tomography (VCT) attenuation correction system that significantly reduces artifacts in the images caused by overlying tissues increasing interpretive ease and accuracy. The revolutionary X-ACT approach takes advantage of the full 24-inch wide detector array eliminating truncation and generating high-precision transmission maps improving the overall quality of SPECT studies. The X-ACT attenuation correction system offers high accuracy, fast acquisition, low dose (5 ?Sv / study) and superb reliability. The system’s high-speed triple-head solid-state design combined with nSPEED software allows the combined cardiac SPECT emission and transmission acquisitions to be performed in as little as five minutes. The Cardius X-ACT system increases diagnostic confidence in nuclear cardiology and raises the standard in the industry for overall SPECT system performance.

Digirad is working with a number of top luminary centers in nuclear cardiology, including the Biomedical Institute in Los Angeles, Jefferson Heart Institute in Philadelphia and University Cardiovascular Medical
Group of UCLA in Los Angeles. Results of an extensive multi-center evaluation of the X-ACT technology will be presented during upcoming events including SNM 2009 in Toronto and ASNC 2009 in Minneapolis.

For more information: www.digirad.com

Related Content

advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Sponsored Content | Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
xSPECT Quant technology, SPECT/CT, Symbia Intevo, Siemens Healthineers, RSNA 2016
News | SPECT Imaging | December 06, 2016
December 6, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
Siemens Healthineers, Symbia Intevo SPECT/CT system, xSPECT Quant, RSNA 2016
Technology | SPECT-CT | October 18, 2016
October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healt
PET/CT

There is a growing focus on early diagnosis and prevention. Here, PET/CT imaging is used to look inside the stress center of the brain.

Feature | Imaging | September 07, 2016 | By Kirill Shalyaev, Ph.D.
Advanced imaging and hybrid modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), positron...
Valiance X12, SPECT/CT, CZT detectors, clinical trial

Tc99m MDP SPECT bone study images of a 35 year old male with right ankle pain. Top: Valiance X12. Bottom: Analog SPECT. Image courtesy of Molecular Dynamics.

News | SPECT-CT | August 24, 2016
Molecular Dynamics has successfully completed the first phase of a clinical trial to evaluate the Valiance X12 whole-...
GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install
News | SPECT-CT | May 05, 2016
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose...
UltraSPECT, dose management, lower dose SPECT

UltraSPECT's image reconstruction software can be used on older SPECT systems to allow lower-dose imaging. This is an example of the software's imaging capability using between 30-50 percent less dose.

Feature | April 20, 2015 | Dave Fornell
Nuclear myocardial perfusion imaging (MPI) with positron emission tomography (PET) and single-photon emission computed...
radiotherapeutics, nuclear medicine, PET, SPECT, MEDraysintell
News | March 10, 2015
The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell...
Overlay Init